Abstract:<p>CRISPR/Cas9 gene editing enables the treatment of hearing loss in congenitally deaf neonatal mice via both viral and non-viral delivery. While adeno-associated virus (AAV)-mediated gene delivery systems have been shown to be effective tools for gene replacement in the inner ear, application of the AAV-mediated CRISPR/Cas9 gene-editing approach for this purpose is yet to be documented. Based on our previous findings, we focused on the effects of several AAVs delivered via canalostomy injection in adult mice. Among the AAVs examined, AAV8 showed the greatest efficiency and specificity in transducing inner hair cells (IHC). The ability of Cre-expressing AAV8 to activate Cas9 in floxed-Cas9 knock-in (Cas9 KI) mice was further evaluated. We compared the effects of six different promoters (CMV, CAG, hSyn, CaMKIIa, GFAP, and ALB) of AAV8 delivered to the inner ear of adult Cas9 KI mice. Our findings showed that three AAV groups (CMV, CAG, and hSyn promoters) infected the inner ear efficiently with different tropism. Notably, AAVs with CMV, CAG, and hSyn promoters infected diverse cell types in mature murine cochleae, including IHCs. In particular, AAV8-hSyn showed high affinity to IHCs and spiral ganglion neurons (SGN). Neither the AAV8 virus itself (except AAV8-CAG) nor the surgical procedures used caused damage to HCs or impaired normal hearing. Our findings indicate that injection of AAV-Cre into mature inner ear efficiently induces Cas9 activation to achieve safe and efficient gene editing and different constituent promoters confer diverse infection patterns in cochlea, expanding the repertoire of gene-editing tools for regulating gene expression in target cells of the inner ear as part of the collective effort to rescue genetic hearing loss and develop effective gene therapy techniques.</p>

In Vivo CRISPR-Cas9-mediated DNA Chop Identifies a Cochlear Outer Hair Cell-Specific Enhancer

Reduction in Noise-Induced Functional Loss of the Cochleae in Mice with Pre-Existing Cochlear Dysfunction Due to Genetic Interference of Prestin

Outer Hair Cell-Specific Prestin-Creert2 Knockin Mouse Lines

Precise Detection of CRISPR-Cas9 Editing in Hair Cells in the Treatment of Autosomal Dominant Hearing Loss

Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo

Deletion of a Long-Range Dlx5 Enhancer Disrupts Inner Ear Development in Mice

Characterization of promoters for adeno-associated virus mediated efficient Cas9 activation in adult Cas9 knock-in murine cochleae

Deletion of Exons 17 and 18 in Prestin’s STAS Domain Results in Loss of Function

In vivo outer hair cell gene editing ameliorates progressive hearing loss in dominant-negative Kcnq4 murine model

Dual expression of Atoh1 and Ikzf2 promotes transformation of adult cochlear supporting cells into outer hair cells

The frequency dependence of prestin-mediated fast electromotility for mammalian cochlear amplification

CRISPR/Cas9-mediated exon skipping to restore premature translation termination in a DFNB4 mouse model

Abnormal Mrna Splicing but Normal Auditory Brainstem Response (ABR) in Mice with the Prestin (SLC26A5) IVS2-2A>G Mutation.

Treatment of autosomal recessive hearing loss via in vivo CRISPR/Cas9-mediated optimized homology-directed repair in mice

Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor

Engineering of the AAV-Compatible Hair Cell-Specific Small-Size Myo15 Promoter for Gene Therapy in the Inner Ear

An In Vitro Study on Prestin Analog Gene in the Bullfrog Hearing Organs

Evaluation of an Independent Prestin Mouse Model Derived from the 129S1 Strain

Three distinct Atoh1 enhancers cooperate for sound receptor hair cell development

Characterizing a Novel Vglut3-P2a-icreer Knockin Mouse Strain in Cochlea.

A base editor for the long-term restoration of auditory function in mice with recessive profound deafness